慢性肺源性心脏病心力衰竭临床治疗探析

Clinical treatment analysis of chronic pulmonary heart disease heart failure

目的:探讨慢性肺源性心脏病心力衰竭临床治疗方法及其疗效。方法:2012年1月-2013年12月收治慢性肺源性心脏病心力衰竭患者50例,随机数字法将其分为对照组和观察组,各25例,对照组给予吸氧、平喘、利尿、抗感染等常规治疗,观察组在对照组基础上采取红花黄色素注射液联合硝普钠治疗,比较两组治疗效果。结果:观察组显效16例(64%),好转7例(28%),治疗总有效率92%;对照组显效6例(24%),好转12例(48%),治疗总有效率72%。观察组治疗总有效率明显高于对照组,P<0.05。另外,观察组治疗后LVEF、PAP水平明显优于对照组,P<0.05。结论:红花黄色素联合硝普钠治疗慢性肺源性心脏病心力衰竭效果显著,不良反应少,可深入研究利用。

Objective:To investigate the clinical treatment and curative effect of the chronic pulmonary heart disease heart failure. Methods:50 patients with chronic pulmonary heart disease heart failure were selected from January 2012 to December 2013.They were divided into the control group and the observation group with 25 cases in each according to the method of random number. The control group were treated with oxygen,asthma,diuresis,anti infection and other conventional treatment.The observation group were treated with the safflower yellow pigment injection combined with sodium nitroprusside based on the control group.We compared the treatment effects between the two groups.Results:The observation group were cured in 16 cases(64%),improved in 7 cases(28% ),and the total efficiency of treatment was 92% ;the control group were cured in 6 cases(24% ),improved in 12 cases(48%),and the total efficiency of treatment was 72%;the total effective rate of the observation group was significantly higher than that of the control group,P<0.05.In addition,the observation group after the treatment,the LVEF,PAP levels significantly better than those of the control group,P<0.05.Conclusion:The effect of safflower yellow combined with sodium nitroprusside in the treatment of chronic pulmonary heart disease heart failure is significantly.It has less adverse reactions.So it can be worthy of further research and use.